Concepedia

Toshiyuki Sawa

TS

Statistics

Publications

108

Citations

8.8K

H-Index

35

Active since

1976

Affiliations

University of Yamanashi(Current)

Gifu Municipal Hospital

Takeda (Japan)

Hiroshima University

Kindai University

Toshiyuki Sawa is an author at University of Yamanashi specializing in mechanics of materials, engineering, and mechanical engineering.

ORCID

Top concepts

Publications per year

1976–2021

108

Publications

108

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.

Yukio Ando, Hideo Saka, Maki Ando et al. · PubMed · 2000 · 788 citations

, , +14

Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)

Shinzoh Kudoh, Koji Takeda, Kazuhiko Nakagawa et al. · Journal of Clinical Oncology · 2006 · 365 citations · Full text

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105

Nobuyuki Yamamoto, Kazuhiko Nakagawa, Yasumasa Nishimura et al. · Journal of Clinical Oncology · 2010 · 293 citations · Full text

Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)

Shinji Atagi, Masaaki Kawahara, Akira Yokoyama et al. · The Lancet Oncology · 2012 · 232 citations

, , +8

1–5 of 108